Neurofilament light as a translational biomarker from preclinical drug discovery to clinical application In this interview, industrial expert Phillip Mitchell discusses the role of NFL-Biomarkers in discovering CNS medicines, research into neurodegenerative diseases,…
New compound shows promise in Alzheimer’s preclinical models A multidisciplinary team of scientists led by Kurt Brunden, Ph.D., at the University of Pennsylvania’s Perelman School of Medicine, and…
